Amarin Pharma, Inc. et al v. Roxane Laboratories, Inc. et.al,
Filing
166
ORDER that pending before the Court is ECF No. 165 Motion to modify the discovery plan and scheduling order. A response to be filed no later than 12/27/2018 and any reply be filed no later than 1/3/2019. Signed by Magistrate Judge Nancy J. Koppe on 12/20/2018. (Copies have been distributed pursuant to the NEF - KW)
1
2
3
4
5
6
7
UNITED STATES DISTRICT COURT
8
DISTRICT OF NEVADA
9
10
AMARIN PHARMA, INC., et al.,
Case No.: 2:16-cv-02525-MMD-NJK
Plaintiff,
11
Order
12
v.
13
HIKMA PHARMACEUTICALS USA INC.,
et al.,
14
[Docket No. 165]
Defendants.
15
16
Pending before the Court is Defendants’ motion to modify the discovery plan and
17 scheduling order, filed on an emergency basis. Docket No. 165. A response shall be filed no later
18 than December 27, 2018, and any reply shall be filed no later than January 3, 2019.
19
IT IS SO ORDERED.
20
Dated: December 20, 2018.
21
______________________________
Nancy J. Koppe
United States Magistrate Judge
22
23
24
25
26
27
28
1
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?